Visualisation and Quantitative Analysis of the Rodent Malaria Liver Stage by Real Time Imaging
暂无分享,去创建一个
Robert W. Sauerwein | Ivo Que | Miguel Prudêncio | Geert-Jan van Gemert | M. Mota | C. Janse | A. Waters | G. van Gemert | R. Sauerwein | B. Franke-Fayard | J. Ramesar | Shahid M. Khan | M. Prudêncio | C. Hermsen | I. Que | Chris J. Janse | Andrew P. Waters | A. Luty | C. Lowik | J. Fonager | B. Douradinha | Jannik Fonager | Ivo H. J. Ploemen | Bruno G. Douradinha | Jai Ramesar | Adrian J. F. Luty | Cornelus C. Hermsen | Fernanda G. Baptista | Maria M. Mota | Clemens W. G. M. Lowik | Blandine M. D. Franke-Fayard | I. Ploemen | Fernanda Baptista | Jannik Fonager
[1] M. Mota,et al. A Small Molecule Inhibitor of Signal Peptide Peptidase Inhibits Plasmodium Development in the Liver and Decreases Malaria Severity , 2009, PloS one.
[2] M. Aepfelbacher,et al. Alteration of the parasite plasma membrane and the parasitophorous vacuole membrane during exo-erythrocytic development of malaria parasites. , 2009, Protist.
[3] C. Janse,et al. Simple and sensitive antimalarial drug screening in vitro and in vivo using transgenic luciferase expressing Plasmodium berghei parasites. , 2008, International journal for parasitology.
[4] M. Leippe,et al. An efficient fluorimetric method to measure the viability of intraerythrocytic Plasmodium falciparum , 2008, Biological chemistry.
[5] J. Craft. Challenges facing drug development for malaria. , 2008, Current opinion in microbiology.
[6] Martijn A. Huynen,et al. Proteomic Profiling of Plasmodium Sporozoite Maturation Identifies New Proteins Essential for Parasite Development and Infectivity , 2008, PLoS pathogens.
[7] G. van Gemert,et al. Temperature Shift and Host Cell Contact Up-Regulate Sporozoite Expression of Plasmodium falciparum Genes Involved in Hepatocyte Infection , 2008, PLoS pathogens.
[8] M. Mota,et al. Genistein-Supplemented Diet Decreases Malaria Liver Infection in Mice and Constitutes a Potential Prophylactic Strategy , 2008, PloS one.
[9] P. Rasoanaivo,et al. Isolation and antimalarial activity of new morphinan alkaloids on Plasmodium yoelii liver stage. , 2008, Bioorganic & medicinal chemistry.
[10] R. Price,et al. Plasmodium vivax trophozoites insensitive to chloroquine , 2008, Malaria Journal.
[11] S. Kappe,et al. Malaria: progress, perils, and prospects for eradication. , 2008, The Journal of clinical investigation.
[12] Nicholas J White,et al. Vivax malaria: neglected and not benign. , 2007, The American journal of tropical medicine and hygiene.
[13] S. Kappe,et al. Release of Hepatic Plasmodium yoelii Merozoites into the Pulmonary Microvasculature , 2007, PLoS pathogens.
[14] R. Bachelier,et al. Advances in optical imaging and novel model systems for cancer metastasis research , 2007, Clinical & Experimental Metastasis.
[15] S. Thiberge,et al. [A new view of malaria provided by parasite imaging]. , 2007, Bulletin de l'Academie nationale de medecine.
[16] K. Matuschewski,et al. Hitting malaria before it hurts: attenuated Plasmodium liver stages , 2007, Cellular and Molecular Life Sciences.
[17] M. Mota,et al. Dissecting in vitro host cell infection by Plasmodium sporozoites using flow cytometry , 2007, Cellular microbiology.
[18] S. Shorte,et al. In vivo imaging of malaria parasites in the murine liver , 2007, Nature Protocols.
[19] S. Hoffman,et al. Prevention and treatment of vivax malaria , 2007, Current infectious disease reports.
[20] J. Carlton,et al. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. , 2007, The Journal of infectious diseases.
[21] Charl P. Botha,et al. Integrated visualization of multi-angle bioluminescence imaging and micro CT , 2007, SPIE Medical Imaging.
[22] B. Rice,et al. Three-dimensional reconstruction of in vivo bioluminescent sources based on multispectral imaging. , 2007, Journal of biomedical optics.
[23] David G Lalloo,et al. UK malaria treatment guidelines. , 2007, The Journal of infection.
[24] S. Kappe,et al. A clash to conquer: the malaria parasite liver infection , 2006, Molecular microbiology.
[25] D. Wirth,et al. High-Throughput Plasmodium falciparum Growth Assay for Malaria Drug Discovery , 2006, Antimicrobial Agents and Chemotherapy.
[26] Ana Rodriguez,et al. The silent path to thousands of merozoites: the Plasmodium liver stage , 2006, Nature Reviews Microbiology.
[27] S. Kappe,et al. Quantitative isolation and in vivo imaging of malaria parasite liver stages. , 2006, International journal for parasitology.
[28] Rogerio Amino,et al. Manipulation of Host Hepatocytes by the Malaria Parasite for Delivery into Liver Sinusoids , 2006, Science.
[29] M. Mota,et al. Infection by and protective immune responses against Plasmodium berghei ANKA are not affected in macrophage scavenger receptors A deficient mice , 2006, BMC Microbiology.
[30] Kevin G Rice,et al. Quantitative bioluminescence imaging of transgene expression in vivo. , 2006, Analytical biochemistry.
[31] S. Levy,et al. Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species , 2006, Cellular microbiology.
[32] F. Cohen,et al. Searching for New Antimalarial Therapeutics amongst Known Drugs , 2006, Chemical biology & drug design.
[33] V. Heussler,et al. In vivo imaging enters parasitology. , 2006, Trends in parasitology.
[34] R. Sauerwein,et al. New Approach for High-Throughput Screening of Drug Activity on Plasmodium Liver Stages , 2006, Antimicrobial Agents and Chemotherapy.
[35] Ivo Que,et al. Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] R. Ménard,et al. In vivo imaging of malaria parasites--recent advances and future directions. , 2005, Current opinion in microbiology.
[37] David K Welsh,et al. Bioluminescence imaging in living organisms. , 2005, Current opinion in biotechnology.
[38] M. Mota,et al. Malaria Vaccines: Back to the Future? , 2005, Science.
[39] K. Rieckmann,et al. Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria. , 2004, The Journal of infectious diseases.
[40] Chris J Janse,et al. A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. , 2004, Molecular and biochemical parasitology.
[41] V. Nussenzweig,et al. Quantitative Plasmodium sporozoite neutralization assay (TSNA). , 2004, Journal of immunological methods.
[42] S. Croft,et al. Antimalarial drug discovery: efficacy models for compound screening , 2004, Nature Reviews Drug Discovery.
[43] Ana Rodriguez,et al. Invasion of mammalian host cells by Plasmodium sporozoites , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.
[44] D. Braitman,et al. A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[45] M. Tsuji,et al. Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR. , 2001, International journal for parasitology.
[46] V. Sharma,et al. Plasmodium vivax Polymorphism in a Clinical Drug Trial , 2001, Clinical Diagnostic Laboratory Immunology.
[47] H. D. del Portillo,et al. Malaria parasites contain two identical copies of an elongation factor 1 alpha gene. , 1998, Molecular and biochemical parasitology.
[48] W. Milhous,et al. The chemotherapy of rodent malaria. LI. Studies on a new 8-aminoquinoline, WR 238,605. , 1993, Annals of tropical medicine and parasitology.
[49] T. McCutchan,et al. Plasmodium berghei: quantitation of in vitro effects of antimalarial drugs on exoerythrocytic development by a ribosomal RNA probe. , 1991, Experimental parasitology.
[50] S. Meshnick,et al. In vitro effects of primaquine and primaquine metabolites on exoerythrocytic stages of Plasmodium berghei. , 1990, The American journal of tropical medicine and hygiene.
[51] P. Nguyen-Dinh,et al. In vitro activity of antimalarial compounds on the exoerythrocytic stages of Plasmodium cynomolgi and P. knowlesi. , 1989, The American journal of tropical medicine and hygiene.
[52] D. Warhurst,et al. The chemotherapy of rodent malaria. XLIV. Studies on the mode of action of CM 6606, an indolo (3,2-c) quinoline N-oxide. , 1989, Annals of tropical medicine and parasitology.
[53] V. Nussenzweig,et al. Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro. , 1987, Journal of immunology.
[54] W. Peters. Chemotherapy of Rodent Malaria. , 1981 .
[55] H. Most,et al. Rodent systems (Plasmodium berghei-Anopheles Stephensi) for screening compounds for potential causal prophylaxis. , 1975, The American journal of tropical medicine and hygiene.
[56] W. Borkowsky,et al. HIV protease inhibitors inhibit the development of preerythrocytic-stage plasmodium parasites. , 2009, The Journal of infectious diseases.
[57] J. Sattabongkot,et al. Culture of exoerythrocytic stages of the malaria parasites Plasmodium falciparum and Plasmodium vivax. , 2009, Methods in molecular biology.
[58] K. Matuschewski,et al. High efficiency transfection of Plasmodium berghei facilitates novel selection procedures. , 2006, Molecular and biochemical parasitology.
[59] C. Janse,et al. Real-time in vivo imaging of transgenic bioluminescent blood stages of rodent malaria parasites in mice , 2006, Nature Protocols.
[60] C. Janse,et al. High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei , 2006, Nature Protocols.
[61] T. Blackwell,et al. Bioluminescence imaging. , 2005, Proceedings of the American Thoracic Society.
[62] M. Mota,et al. Parasitology. Malaria vaccines: back to the future? , 2005, Science.
[63] J. Holenz,et al. Retarded development of exoerythrocytic stages of the rodent malaria parasite Plasmodium berghei in human hepatoma cells by extracts from Dioncophyllaceae and Ancistrocladaceae species. , 1997, International journal for parasitology.